What is the spectrum and risk of proarrhythmia associated with different antiarrhythmic drugs?
Different antiarrhythmic drugs carry varying risks and spectrums of proarrhythmia, highlighting the need for early identification and management in clinical practice.
The investigation showed the spectrum and risk of AAD-associated cardiac arrhythmias varied among different AAD therapies. The early identification and management of AAD-associated arrhythmias are of great importance in clinical practice.
Wang et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: